Downloads per author, site-wide

Preprints

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

oncology more details view paper

• Downloaded 5,852 times
• Download rankings, all-time:
  • Site-wide: 2,494
  • In oncology: 2
• Year to date:
  • Site-wide: 11,992
• Since beginning of last month:
  • Site-wide: 7,983

A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis

infectious diseases more details view paper

• Downloaded 5,647 times
• Download rankings, all-time:
  • Site-wide: 2,604
  • In infectious diseases: 674
• Year to date:
  • Site-wide: 33,396
• Since beginning of last month:
  • Site-wide: 34,057

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study)

infectious diseases more details view paper

• Downloaded 4,301 times
• Download rankings, all-time:
  • Site-wide: 3,774
  • In infectious diseases: 843
• Year to date:
  • Site-wide: 21,020
• Since beginning of last month:
  • Site-wide: 24,487

Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 Long Term Care Facilities (VIVALDI study)

geriatric medicine more details view paper

• Downloaded 832 times
• Download rankings, all-time:
  • Site-wide: 42,612
  • In geriatric medicine: 18
• Year to date:
  • Site-wide: 91,997
• Since beginning of last month:
  • Site-wide: None